Move Inc. (NASDAQ:MOVE):
Move Inc. (NASDAQ:MOVE) operates an online network of Websites for real estate search, finance, and moving and home enthusiasts in North America. The company primarily operates REALTOR.com, a Website that offers property listings, other property information, and various services to real estate franchises, brokers, and agents, as well as non-real estate related advertisers, such as personal banking and mortgage companies, insurance providers, home improvement retailers, moving service providers, and other consumer product and service companies.
The Delbrook Resources Opportunities Master Fund was up 9.2% for May, bringing its year-to-date return to 33%. Q1 2021 hedge fund letters, conferences and more Dellbrook is an equity long/ short fund that focuses exclusively on the metals and mining sector. It invests mainly in public companies focused on precious, base, energy and industrial metals Read More
As recently as 60 days ago, Move Inc. (NASDAQ:MOVE) was expected to report earnings of $0.04 per share. That has been revised to $0.00 per share when they report after the close of the market today. Revenue is expected to come in at $53.81 million up 12.7% from $47.74 million a year ago.
Leucadia National Corp. (NYSE:LUK):
Leucadia National Corp. (NYSE:LUK) engages in beef processing, manufacturing, gaming entertainment, real estate activities, medical product development, and winery operations in the United States and internationally. The stock has been trading high after hitting a 52-week high last week.
Leucadia National Corp. (NYSE:LUK) is expected to report earnings of $0.36 per share when they report after the bell today. Revenues are expected to come in at $2.9 billion up from year-to-year revenue of $2.4 billion. For the fiscal year the consensus is calling for revenues of $12.1 billion with sales expected to come in at that number next year as well.
Gilead Sciences, Inc. (NASDAQ:GILD):
Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia.
The consensus estimate is calling for earnings of $0.47 a share, a rise from $0.31 per share a year-over-year.
The consensus estimate has risen from $0.46 over the past three months. Analysts are looking for earnings of $1.94 per share for the fiscal year. Revenue is projected to be 13 percent above the year-earlier total of $2.28 billion at $2.58 billion for the quarter. For the year, revenue is expected to arrive at $10.68 billion.
In each of the last four quarters, the company has seen double-digit year-over-year revenue growth.
Fluor Corporation (NEW) (NYSE:FLR):
Fluor Corporation (NEW) (NYSE:FLR), through its subsidiaries, provides engineering, procurement, construction, maintenance, and project management services worldwide. The company operates in five segments: Oil & Gas, Industrial & Infrastructure, Government, Global Services, and Power.
Analysts are expecting Fluor Corporation (NEW) (NYSE:FLR) to report earnings of $0.96 per share, up 5.5% from a year ago when it reported earnings of $0.91 per share.
The consensus estimate has backtracked from $0.98 over the past three months. For the fiscal year, analysts are projecting earnings of $4.17 per share. Revenue is projected to be 9.9 percent above the year-earlier total of $6.29 billion at $6.91 billion for the quarter. For the year, revenue is projected to arrive at $29.07 billion.
Revenue has grown by double digits year-over-year for four consecutive quarters. Over that period, revenue has grown by an average of 18.3 oercent.
Dole Food Company, Inc. (NYSE:DOLE):
Dole Food Company, Inc. (NYSE:DOLE) engages in sourcing, growing, processing, marketing, and distributing fresh fruits and vegetables to wholesale, retail, and institutional customers; and other food product companies.
The consensus expects earnings of $0.15 when Dole Food Company, Inc. (NYSE:DOLE) reports after market close today. This number is up from $0.14 a year ago. For the fiscal year, analysts are eying earnings of $0.60 compared to $0.49 per share last year.
Revenue is expected to arrive at $1.05 billion down over 35% from year-over-year sales of $1.63 billion. Fiscal year revenues look better with analysts expecting revenues of $4.17 billion down just under 2% from year-over-year revenue of $4.25 billion.